Bridgehead Nitrogen Thiazolo[3,2-a]pyrimidine: A Privileged Structural Framework in Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|17|15|1488-1499

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.17, Iss.15, 2017-09, pp. : 1488-1499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

6-Acetyl-5H-thiazolo[3,2-a]pyrimidine Derivatives as the Novel Acetylcholinesterase Inhibitors: Design, Synthesis, and Biological Activity

By  

Medicinal Chemistry, Vol. 9, Iss. 5, 2013-08 ,pp. : 703-709

Bentham Science Publishers

Access to resources Recommend Favorite

Reactions of thioamides and alkali metal salts of dithiocarbamates with 2-bromo-7-methyl-5-oxo-5H-1,3,4-thiazolo[3,2-a]pyrimidine and antimicrobial activity of products

By Kukaniev M.   Salimov T.   Murvatulloeva M.   Imatshoev I.  

Pharmaceutical Chemistry Journal, Vol. 40, Iss. 8, 2006-08 ,pp. : 421-423

Springer Publishing Company

Access to resources Recommend Favorite

Rhodanine as a Privileged Scaffold in Drug Discovery

By  

Current Medicinal Chemistry, Vol. 16, Iss. 13, 2009-05 ,pp. : 1596-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Privileged Scaffolds or Promiscuous Binders: A Glance of Pyrrolo[2,1-f][1,2,4]triazines and Related Bridgehead Nitrogen Heterocycles in Medicinal Chemistry

By  

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1528-1548

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1488-1508

Bentham Science Publishers

Access to resources Recommend Favorite